Introduction: Frequency of extended-spectrum beta-lactamases (ESBLs) and its variants may vary in different geographical areas, as reports indicate their spread in some certain communities. The aim of this study was to determine the frequency of ESBLs in strains of Klebsiella and E. coli, isolated from patients hospitalized in teaching hospitals of Yazd. Methods: This cross-sectional study was carried out on samples including E. coli and Klebsiella strains collected from laboratories of Shahid Sadoughi and Shahid Rahnemoun hospitals in Yazd, Iran in the period of 2011-2012. The colonies which were positive in lactose Eosin methylene-blue (EMB) medium were identified by biochemical methods, and 270 strains of Klebsiella and E. coli were isolated. Collected data and information were analyzed using Fisher's exact test and descriptive statistics such as mean in SPSS software, version 15, at a significant level of 0.05. Results: In this study, 270 samples were examined, including 152 samples of E. coli (56.3%) and 118 samples of Klebsiella pneumonia (43.7%). Among the 152 samples of E. coli, 45 strains (30%) were producers of ESBLs. In addition, among the 118 samples of Klebsiella pneumonia, 44 strains (37.3%) were producers of ESBLs. E. coli strains showed the most resistance to Cefotaxime (100%), Ceftazidime (97.7%), and Cefepime (75.5%) respectively and Klebsiella strains showed the most resistance to Cefotaxime (100%), Ceftazidime (100%) and Cefepime (79.5%), respectively. Conclusion: Frequency of ESBLs in Klebsiella strains was higher than E. coli strains. No significant relationship was found between frequency of ESBLs and age or gender. In addition, E. coli strains showed the highest sensitivity to Imipenem, Amoxicillin/clavulanate, and Ciprofloxacin, while the highest antibiotic sensitivity of Klebsiella strains was shown to be to Piperacillin, Imipenem, and Amoxicillin/clavulanate.
Introduction
Infections, caused by beta-lactam-resistant organisms, has increased due to the production of numerous enzymes in recent years (1) . Extended-spectrum beta-lactamases (ESBLs) are a group of beta-lactamases that are most often derived from mutation in the older beta-lactamases that alters the amino acid configuration around the active site of these β-lactamases (2) . ESBL production by organisms such as Enterobacteriaceae has created challenges to clinical microbiologists and clinicians (3) . The prevalence of antibiotic resistance among E. coli and Klebsiella pneumoniae has been increased markedly in recent years by production of ESBLs (4) . E. coli and Klebsiella pneumonia are mostly ESBL producers (5) . One of the ways of resistance in Gram-negative bacteria is the production of ESBLs. The family Enterobacteriaceae produce ESBLs resulting in resistance to antibiotics (6) . Frequency of ESBLs and its variants may vary in different geographical areas, as reports indicate their spread in some certain communities. Resistance of organisms to face antibiotics has become a problem around the world with serious consequences on the treatment of infectious diseases (1) . Hence, the aim of present study was to determine the frequency of ESBLs in strains of Klebsiella and E. coli isolated from patients hospitalized in teaching hospitals of Yazd in the period 2011-2012.
Material and Methods

Design and setting
The present research was a cross-sectional, descriptive-analytic study. Using total enumeration method, all samples including E. coli and Klebsiella strains collected from laboratories of Shahid Sadoughi and Shahid Rahnemoun hospitals in Yazd Province were studied. Eosin methylene-blue (EMB) lactose sucrose agar was used for bacteria culture. EMB is a useful differential-selective medium for isolation and identification of Gram-negative intestinal bacteria. Eosin y and methylene blue are optional components added to prevent the growth of Gram-positive bacteria, while allowing the Gram-negative ones to grow. Lactose carbohydrates are also added to separate the isolates based on fermentation of lactose and sucrose. E. coli is a lactose-fermenting coliform which typically creates blue-black colonies with a greenish metallic luster. Other fermenting coliforms such as Enterobacter create pink colonies. Non-fermenting colonies are transparent, amber or colorless (7).
Sample collection
Gram-negative bacilli, isolated from different clinical specimens in laboratories of Shahid Sadoughi and Shahid Rahnemoun hospitals in Yazd Province were collected. After filling out the questionnaire (demographic information such as, name, age, gender, sample type, ward, and hospital and information on tests such as bacteria name, presence or absence of ESBLs, and antibiogram result), samples were transferred to the Microbiology Laboratory of Yazd University of Medical Sciences. Samples were cultured in EMB medium (Merck Company, Germany) and kept at a temperature of 37 °C for 24 hours. The colonies which were positive in lactose EMB medium (those that created a deep pink color or metallic luster) were identified by biochemical methods and 270 strains of Klebsiella and E. coli were isolated.
The tests used for the identification of bacteria
Lactose fermentation (in the Triple Sugar Iron agar), gas production (in the Triple Sugar Iron agar), urea hydrolysis (in the urea agar), the use of citrate (in the Simon Citrate), movement (in the SH2-Indol-Motility medium), indole production (in the SH2-Indol-Motility medium), methyl red test (in the Methyl Red-Vegesproskaure broth), and VP wax test (in the Methyl Red-Vegesproskaure broth).
Measurement of bacteria sensitivity to antibiotics
Sensitivity of E. coli and Klebsiella isolates to antibiotics of Gentamicin, Ciprofloxacin, Cotrimoxazole, Clavulanate/amoxicillin, Imipenem, Piperacillin, Cefepime, Ceftazidime, and Cefotaxime was measured by the disk diffusion method (Kirby-Bauer) according to CLSI protocols, using bacterial suspension with a dilution equivalent to opacity of half pipe McFarland and the solid medium of Muller-Hinton (Merck Company, Germany). For this purpose, a bacterial suspension with a dilution equivalent to opacity of half pipe McFarland was prepared (1.5×10 8 bacteria). Then, the suspension was inoculated on the plates containing Müller-Hinton agar medium and cultured with GRASS method. Antibiotics disks were put on the medium using sterile forceps, as they had a distance of 20 mm from each other and 15 mm from the wall of plate. The plates were incubated for 18 hours at a temperature of 37°C. After the incubation period, the diameter of areola related to lack of bacterial growth around the disc, was measured using a ruler (in mm) and compared to the table provided in CLSI protocols and then sensitivity (s), intermediate (I), and resistant (R) were qualitatively reported. All tests were performed on the standard strain of E. coli ATCC25922 as the control.
Studying the existence of ESBLs
For this purpose, combination disk method and Cefotaxime (CTX: 30μg), Cefotaxime-clavulanic acid (CTX 30μg/CLAV 10μg), Ceftazidime (CTX: 30μg), and Ceftazidime-clavulanic acid (CTX 30μg/CLAV 10μg) disks (Mast Company, England) were used. First of all, a bacterial suspension with a dilution equivalent to opacity of half pipe McFarland was prepared and then inoculated on the plates containing Müller-Hinton agar medium by a swab and cultured with GRASS method. The results were read after incubation. According to the manufacturer's instructions, if the diameter of areola related to lack of bacterial growth around the Ceftazidime-clavulanic acid or
Cefotaxime-clavulanic acid disks shows an increase more than 5 mm compared to the diameter of areola related to lack of growth around Ceftazidime or Cefotaxime, this strain is considered as a producer of ESLBs.
Data analysis
Collected data and information were analyzed using descriptive statistics such as Fisher's exact test and mean in SPSS software, version 15 (SPSS Inc, Chicago, Illinois, USA) , at a significant level of 0.05.
Results
In this study, 270 samples were examined including 152 samples of E. coli (56.3%) and 118 samples of Klebsiella pneumoniae (43.7%). Among the 270 studied strains, 89 strains (33%) were producers of ESBLs and 181 strains (67%) were negative in terms of ESBLs production. Among the 152 samples of E. coli, 45 strains (30%) were producers of ESBLs. In addition, among the 118 samples of Klebsiella pneumoniae, 44 strains (37.3%) were producers of ESBLs ( 
Discussion
Since the 1980s, a new group of antibiotics called oxyimino cephalosporins, which were resistant to hydrolytic activity of beta-lactamase, were used for treatment of infections caused by Gram-negative bacteria (8, 9) . In early 1990, ESBLs produced by Gram-negative bacteria, showed resistance to cephalosporins such as ceftazidime and cefotaxime, with higher resistance to cefotaxime than ceftazidime (10) . ESBLs enzyme gene is related to plasmid and causes this enzyme to be easily transmitted among bacteria. In addition to the gene of ESBLs, most of these plasmids also transmit the genes resistant to several beta lactam and non-beta-lactam antibiotics (including aminoglycosides, cotrimoxazoles, and fluoroquinolones). As a result, most of isolated ESBLs are resistant to many types of antibiotics (11) . In the present study, among the 154 strains of E. coli, 45 samples (30%) were producers of ESBLs, while this figure in strains of Klebsiella was 44 out of 118 sample (37.3%). Navarro conducted a study on the frequency of E. coli producing ESBLs, and the results showed that production of ESBLs in nosocomial samples of E. coli is 30% (12) . In another study conducted by Ibrahim (2011) (14) . The results of these studies on the frequency of ESBLs in E. coli strains are consistent with the findings of the present study with slight differences. In a study by Romero and two other studies carried out in Turkey, frequency of these enzymes in E. coli has been reported to be 1%, 12%, and 19.5%, respectively (15) (16) (17) . These figures are less than those obtained in the present study. In studies conducted by Ghafourian, Korten in Turkey and Ozgunes, frequency of ESBLs in Klebsiella samples was reported to be 59.2%, 48.7%, and 47%, respectively. These figures are higher than the findings of the present study (15, 17, 18) . In addition, in studies carried out by Romero, prevalence of these enzymes was found to be 2.8% which is less than the figures in this study (16) . As it can be seen in different studies, the frequency of ESBLs enzymes may vary in different regions, cities, and hospitals. In a study conducted in Thailand on various species of Enterobacteriaceae, no statistically significant association was found between age and ESBLs production in bacteria (6) . In another study conducted by Ibrahim et al. on the frequency of ESBLs in E. coli samples in hospitals of Khartoum, Sudan from April to August 2011, no significant difference was observed between samples taken from children and adults in terms of ESBLs production (13) . In the present study, according to the results obtained for age ranges (below 20, 20-40, 40-60, and above 60), no significant relationship was found between age ranges and studied samples (p-value= 1, 0.54, 0.29, and 0.36, respectively). In a study conducted by Luvsansharav et al. on different species of Enterobacteriaceae, E. coli was the most common species producing ESBLs and no statistically significant association was found between gender and ESBL production in bacteria (6) . The relationship between gender and frequency of ESBLs in the present study was not significant, with p-values of 0.3 for men and 0.42 for women. As mentioned in the results, frequency of ESBLs in E. coli and Klebsiella strains in urine, blood, ulcer, CSF, lung secretions, and sputum was 27% and 31.5%, 58.3% and 37.5%, 13.3% and 45%, 40% and 0%, 50% and 46%, and 0% and 33.3%, respectively. The highest frequency of these enzymes in E. coli and Klebsiella strains was obtained in blood culture and lung secretions culture, respectively. None of the findings for frequency of ESBLs in E. coli and Klebsiella strains in different samples were statistically significant. In a study in three hospitals in 3 regions of Iran, 113 samples of Klebsiella pneumoniae were isolated from respiratory tract infection that 67 samples (59.2%) were producers of ESBLs (18) . Accordingly, 17 samples in a hospital in Ilam
